May 11, 2023 / 12:30PM GMT
Operator
Good morning, and welcome to the Knight Therapeutics First Quarter 2023 Results Conference Call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Samira Sakhia. Please go ahead.
Samira Sakhia - Knight Therapeutics Inc. - President, CEO & Director
Thank you, Debbie. Good morning, everyone, and welcome to Knight Therapeutics First Quarter 2023 Conference Call. I'm joined on today's call with Amal Khouri, our Chief Business Officer; Arvind Utchanah, our Chief Financial Officer; and Jeff Martens, our Global VP of Commercial.
I'm excited to report an impressive first quarter results with revenues of over $82 million and a 29% growth compared to the same period last year and record adjusted EBITDA of over $18 million, representing growth of 37% compared to the same period last year. This strong performance is a testament to the hard work and dedication of our team and the continued success of our portfolio across all of our therapeutic areas.
In addition to the continued
Q1 2023 Knight Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot